journal article·2024-05-25Open access

Polyethylene Terephthalate Fiber Modified with Type I Collagen as a 3D Scaffold Material for Bioartificial Liver

Yang Li, Yang Zhang, Jianping Gao, Shuguang Liao, Guifeng Zhang

Applied Sciences· Volume 14· Issue 11

Abstract

Acute and chronic liver failure are clinically significant conditions, and the artificial liver support system (ALSS) is emerging as a novel and effective approach for the clinical management of liver failure. Within this framework, scaffold materials occupy a pivotal position as integral components of the bioreactor. Elevating the performance capabilities of these scaffolds not only augments the therapeutic efficacy of the artificial liver but also lays the groundwork for refining and selecting large-scale hepatocyte culture models. In this study, we introduced a novel hepatocyte scaffold material designated as PET-COL, crafted by coating polyethylene terephthalate (PET) with collagen. This involved a sequence of modifications, including alkaline hydrolysis, EDC/NHS activation and crosslinking, as well as collagen conjugation. The physicochemical attributes of the scaffold were thoroughly characterized by Fourier-transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), second harmonic generation (SHG), water contact angle measurements, and high-performance liquid chromatography–mass spectrometry (HPLC-MS). Furthermore, an investigation into the material’s biological properties was conducted that encompassed SEM (HepaRG growth), fluorescence staining (assessment of cell viability), staining by trypan blue (HepaRG counting), CCK-8 (proliferation of cells), biochemical testing, and immunosorbent assay. Our findings revealed that collagen was covalently bonded to the PET surface, leading to a substantial enhancement in the material’s hydrophilicity (p < 0.001). The quantity of collagen coating was determined to be precisely 33.30 μg per scaffold. Human liver progenitor HepaRG cells thrived on the PET-COL material. Compared with the untreated group, cell viability, albumin secretion, urea synthesis, and the expression levels of CYP3A4 and CPS1 increased significantly (p < 0.001), demonstrating remarkable biological vitality. The PET-COL scaffold, as developed in this study, holds immense potential for application in bioartificial livers.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Tissue Engineering and Regenerative Medicine · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China

School of Chemical and Engineering, University of Chinese Academy of Sciences, Beijing 100049, China

Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China

Funding

National Key R&D Program of China · National Natural Science Foundation of China

References (40)

Show source-provided references
1. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure10.1136/gutjnl-2017-314641 ↗
2. Acute on Chronic Liver Failure in Patients with Alcohol-Associated Hepatitis: A Review10.1016/j.cld.2023.03.009 ↗
3. American Gastroenterological Association Institute guidelines for the diagnosis and management of acute liver failure10.1053/j.gastro.2016.12.026 ↗
4. Acute liver failure10.1016/j.jhep.2021.01.037 ↗
5. Update on the management of acute liver failure10.1097/MCC.0000000000000697 ↗
6. Acute-on-chronic liver failure: Terminology, mechanisms and management10.3350/cmh.2022.0103 ↗
7. Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system10.3748/wjg.v21.i32.9614 ↗
8. Domino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure10.1155/2018/2593745 ↗
9. Kimmann, M., and Trebicka, J. (2023). Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges. J. Pers. Med., 13.10.3390/jpm13071052 ↗
10. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature10.3748/wjg.v25.i27.3634 ↗
11. Randomized trial of spheroid reservoir bioartificial liver in porcine model of posthepatectomy liver failure10.1002/hep.30184 ↗
12. A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure10.1038/s41598-021-82719-x ↗
13. Artificial liver support in acute and acute-on-chronic liver failure10.1097/MCC.0000000000000584 ↗
14. Current evidence for extracorporeal liver support systems in acute liver failure and acute-on-chroliver failure10.1016/j.ccc.2016.03.003 ↗
15. Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure10.3748/wjg.v20.i46.17399 ↗
16. Fabrication and in vitro evaluation of a packed-bed bioreactor based on an optimum two-stage culture strategy10.1016/j.jbiosc.2018.09.010 ↗
17. Safakar, A.Y., Hamel, K.M., Mehrnezhad, A., Jung, J.P., and Park, K. (2019). Development of rolled scaffold for high-density adherent cell culture. Biomed. Microdevices., 22.10.1007/s10544-019-0459-9 ↗
18. HepaRG self-assembled spheroids in alginate beads meet the clinical needs for bioartificial liver10.1089/ten.tea.2019.0262 ↗
19. 3D Co-culture of hepatocyte, a hepatic stellate cell line, and stem cells for developing a bioartificial liver prototype10.14716/ijtech.v11i5.4317 ↗
20. Decellularized liver matrix-modified chitosan fibrous scaffold as a substrate for C3A hepatocyte culture10.1080/09205063.2020.1738690 ↗
21. Selection of a poly urethane membrane for the manufacture of ventricles for a totally implantable artificial heart: Blood compatibility and biocompatibility studies10.1046/j.1525-1594.2000.06504.x ↗
22. Covalent binding of heparin to functionalized PET materials for improved haemocompatibility10.3390/ma8041526 ↗
23. Surface modification on polyethylene terephthalate films with 2-methacryloyloxyethyl phosphorylcholine10.1016/j.msec.2013.03.036 ↗
24. Polymer carriers for drug delivery in tissue engineering10.1016/j.addr.2007.04.001 ↗
25. The materials science of collagen10.1016/j.jmbbm.2015.05.023 ↗
26. A compound scaffold with uniform longitudinally oriented guidance cues and a porous sheath promotes peripheral nerve regeneration in vivo10.1016/j.actbio.2017.12.010 ↗
27. Bioglass incorporation improves mechanical properties and enhances cell-mediated mineralization on electrochemically aligned collagen threads10.1002/jbm.a.36102 ↗
28. Nguyen, T.U., Bashur, C.A., and Kishore, V. (2016). Impact of elastin incorporation into electrochemically aligned collagen fibers on mechanical properties and smooth muscle cell phenotype. Biomed. Mater., 11.10.1088/1748-6041/11/2/025008 ↗
29. Modification of collagen–chitosan matrix by the natural crosslinker alginate dialdehyde10.1016/j.ijbiomac.2015.10.039 ↗
30. Biocompatibility studies of anionic collagen membranes with different degrees of glutaraldehyde cross-linking10.1016/S0142-9612(97)00198-1 ↗
31. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide10.1016/0142-9612(96)81413-X ↗
32. Effect of PET graft coated with silkfibroin via EDC/ NHS crosslink on graft-bone healing in ACL Reconstruction10.1039/C7RA08636A ↗
33. Tissue engineering human placenta trophoblast cells in 3-D fibrous matrix: Spatial effects on cell proliferation and function10.1021/bp990072y ↗
34. Jha, S., Malviya, R., Fuloria, S., Sundram, S., Subramaniyan, V., Sekar, M., Sharma, P.K., Chakravarthi, S., Wu, Y.S., and Mishra, N. (2022). Characterization of Microwave-Controlled Polyacrylamide Graft Copolymer of Tamarind Seed Polysaccharide. Polymers, 14.10.3390/polym14051037 ↗
35. Woźniak, A., Smok, W., Szewczenko, J., Staszuk, M., and Chladek, G. (2024). Influence of Hybrid Surface Modification on Biocompatibility and Physicochemical Properties of Ti-6Al-4V ELI Titanium. J. Funct. Biomater., 15.10.3390/jfb15030052 ↗
36. Tascher, G., Burban, A., Camus, S., Plumel, M., Chanon, S., Le Guevel, R., Shevchenko, V., Van Dorsselaer, A., Lefai, E., and Guguen-Guillouzo, C. (2019). In-depth proteome analysis highlights HepaRG cells as a versatile cell system surrogate for primary human hepatocytes. Cells, 8.10.3390/cells8020192 ↗
37. Contextualizing hepatocyte functionality of cryopreserved HepaRG cell cultures10.1124/dmd.116.069831 ↗
38. Advanced in vitro HepaRG culture systems for xenobiotic metabolism and toxicity characterization10.1007/s13318-018-0533-3 ↗
39. HepaRG microencapsulated spheroids in DMSO-free culture: Novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism10.1007/s00204-014-1320-9 ↗
40. Technological advancements for the development of stem cell-based models for hepatotoxicity testing10.1007/s00204-019-02465-y ↗